Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 0.50 (1.20%)
Spread: 2.00 (4.878%)
Open: 41.50
High: 42.00
Low: 41.50
Prev. Close: 41.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambridge Cognition revenue climbs despite swing to annual loss

Wed, 03rd May 2023 17:21

(Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it had a "transformative" 2022, as revenue climbed 25% against the previous year.

The Cambridge, England-based digital health products technology developer said revenue in 2022 rose to GBP12.6 million, up 25% from GBP10.1 million a year earlier. Services revenue grew by 16% in 2022 to GBP6.5 million, whilst Software revenue climbed 39% to GBP5.0 million.

However, the company swung to a pretax loss of GBP600,000 from a pretax profit of GBP300,000 year-on-year. It also swung to a loss per share of 1.3 pence, from an earnings per share of 1.4 pence.

The financial results for the year were tempered by a slightly slower-than-expected final quarter, as the company experienced delays and scope reduction associated with large orders, Cambridge Cognition explained. It added that market forecasts suggest that this is not representative of a long-term trend.

The company ended 2022 with a contracted order book of GBP17.6 million, which increased further to GBP19.1 million in January, following the acquisition of Winterlight Labs.

Cambridge Cognition bought Winterlight Labs for GBP7.0 million back in January.

Looking ahead, Cambridge Cognition said that its strong contracted order book provides "excellent" revenue visibility through 2023.

"2022 was a transformational year for Cambridge Cognition, marked by significant multi-year orders, sustained revenue growth, and the expansion of our core product set," said Chief Executive Officer Matthew Stork.

"Looking ahead, we remain committed to our objectives of driving revenue and profit growth by increasing our market share through offering the most innovative technology, supported by outstanding scientific evidence and a very experienced team, in the high-value market for CNS drug development."

Shares in Cambridge Cognition closed down 4.6% to 93.00 pence each.

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
15 Feb 2016 09:01

Cambridge Cognition Makes Interim CEO Powell Permanent Boss

Read more
8 Dec 2015 10:06

Cambridge Cognition Launches New Cognitive Assessment System

Read more
20 Nov 2015 07:45

Cambridge Cognition Expects 2015 In Line With 2014 On Contract Wins

Read more
8 Oct 2015 07:14

Cambridge Cognition Signs Two New Licence Agreements

Read more
21 Sep 2015 08:36

Cambridge Cognition Forms Workplace Tests Venture With Shandwell

Read more
10 Sep 2015 08:25

Cambridge Cognition First Half Loss Narrows As Revenue Up 17.7%

Read more
9 Sep 2015 12:46

Cambridge Cognition files second patent application

(ShareCast News) - Cambridge Cognition Holdings has filed a second patent application in the field of systems and methods for assessing cognitive function. The company, which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, said the new a

Read more
9 Sep 2015 07:53

Cambridge Cognition Files Patent For Cognitive Function Assessments

Read more
8 Sep 2015 05:12

Earnings, Trading Statements Calendar - Week Ahead

Read more
7 Sep 2015 15:04

Earnings, Trading Statements Calendar - Week Ahead

Read more
7 Sep 2015 05:15

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Sep 2015 15:11

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Sep 2015 05:22

Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Sep 2015 15:01

Earnings, Trading Statements Calendar - Week Ahead

Read more
1 Jul 2015 11:06

Cambridge Cognition Says Steven Powell To Take Up Interim CEO Role

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.